Cite
HARVARD Citation
Karami, Z. et al. (2020). Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan‐coated nanoemulsion. Journal of biomedical materials research. 108 (3), pp. 717-728. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Karami, Z. et al. (2020). Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan‐coated nanoemulsion. Journal of biomedical materials research. 108 (3), pp. 717-728. [Online].